CONMED (CNMD) Stifel 2024 Healthcare Conference summary

Leadership transition

• CEO Curt Hartman announced his retirement, emphasizing a focus on quality time with family.

• The leadership team reflected on Hartman's career and his transformative impact on the organization.

Portfolio and growth drivers

• The business is structured around General Surgery and Orthopedics, with key franchises in foot & ankle and sports medicine.

• Recent acquisitions (AirSeal, Buffalo Filter, foot & ankle, BioBrace) are seen as major growth platforms, contributing 25%-30% of revenue.

• All segments are focused on minimally invasive approaches, targeting robust, high-growth markets.

• Continuous R&D and portfolio advancement are prioritized to maintain competitiveness and efficiency.

Operational challenges and recovery

• Orthopedic supply chain issues, including supplier bankruptcies and hurricane disruptions, impacted production but are being resolved.

• Most supply chain setbacks are expected to be behind as the company enters 2025, with only minor lingering effects possible.

• The Largo, Florida facility experienced brief hurricane-related shutdowns but has resumed operations and supports the local community.